| 4E-BP1 | Eukaryotic translation initiation factor 4E-binding protein 1 |
| ADC | Antibody-Drug Conjugate |
| AI | Artificial Intelligence |
| APC | Adenomatous Polyposis Coli |
| ARID1A | AT-rich interactive domain-containing protein 1A |
| ATR | Ataxia Telangiectasia and Rad3-related protein |
| CAFs | Cancer-associated fibroblasts |
| CCND1 | Cyclin D1 |
| CCNE1 | Cyclin E1 |
| CDK4/6 | Cyclin-Dependent Kinase 4/6 |
| CK1 | Casein Kinase 1 |
| CN-H | Copy-Number High |
| CN-L | Copy-Number Low |
| CPTAC | Clinical Proteomic Tumor Analysis Consortium |
| CRISPR | Clustered Regularly Interspaced Short Palindromic Repeats |
| CSF | Cerebrospinal Fluid |
| CTC | Circulating Tumor Cell |
| CTNNB1 | Catenin Beta 1 |
| CTx | Chemotherapy |
| ctDNA | Circulating tumor DNA |
| DDR | DNA Damage Repair |
| DKK1 | Dickkopf-related protein 1 |
| DLC1 | Dynein light chain 1 |
| E2 | Estradiol |
| EC | Endometrial Cancer |
| ECM | Extracellular matrix |
| EEC | Endometrioid Carcinoma |
| EGF | Epidermal Growth Factor |
| EIN | Endometrial intraepithelial neoplasia |
| ER | Estrogen Receptor |
| ERα | Estrogen Receptor Alpha |
| ERβ | Estrogen Receptor Beta |
| ESGO | European Society of Gynecological Oncology |
| ESP | European Society of Pathology |
| ESTRO | European Society for Therapeutic Radiotherapy and Oncology |
| EZH2 | Enhancer of Zeste Homolog 2 |
| FGFR | Fibroblast Growth Factor Receptor |
| FIGO | The International Federation of Gynecology and Obstetrics |
| GSK3β | Glycogen Synthase Kinase 3 Beta |
| HER2 | Human Epidermal Growth Factor Receptor 2 |
| HR | Hormone receptor |
| IGF | Insulin-like Growth Factor |
| IGF1 | Insulin-like Growth Factor 1 |
| IL-10 | Interleukin-10 |
| IHC | Immunohistochemistry |
| JAK/STAT | Janus Kinase/Signal Transducer and Activator of Transcription |
| L1CAM | L1 cell adhesion molecule |
| LN | Lymph Node |
| LVSI | Lymphovascular Space Involvement |
| MAPK | Mitogen-activated Protein Kinase |
| MDK | Midkine |
| MMP2 | Matrix Metallopeptidase 2 |
| MMP7 | Matrix Metallopeptidase 7 |
| MMP9 | Matrix metalloproteinase 9 |
| MMR | Mismatch Repair |
| MMRd | Mismatch Repair Deficient |
| MRI | Magnetic Resonance Imaging |
| MSI-H | Microsatellite Instability-High |
| MYC | MYC Proto-Oncogene |
| NCL | Nucleolin |
| NGS | Next-Generation Sequencing |
| NSMP | No Specific Molecular Profile |
| p53abn | p53-abnormal |
| PARP | Poly(ADP-ribose) polymerase |
| PCR-MSI | Polymerase Chain Reaction-based Microsatellite Instability |
| PD-1 | Programmed cell death protein 1 |
| PD-L1 | Programmed death-ligand 1 |
| PET | Positron Emission Tomography |
| PIK3CA | Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
| PIK3R1 | Phosphatidylinositol 3-kinase regulatory subunit alpha |
| PIP2 | Phosphatidylinositol 4,5-bisphosphate |
| PIP3 | Phosphatidylinositol (3,4,5)-trisphosphate |
| POLEmut | POLE ultramutated |
| PORCN | Porcupine O-acyltransferase |
| PR | Progesterone Receptor |
| PRC2 | Polycomb Repressive Complex 2 |
| PTEN | Phosphatase and tensin homolog |
| RTK | Receptor Tyrosine Kinase |
| RTx | Radiotherapy |
| S6K1 | Ribosomal protein S6 kinase beta-1 |
| SERD | Selective Estrogen Receptor Degrader |
| SERMs | Selective Estrogen Receptor Modulators |
| SFRP1 | Secreted Frizzled-related protein 1 |
| SMARCA4 | SWI/SNF Related, Matrix Associated, Actin Dependent Regulator of Chromatin, Subfamily A, Member 4 |
| TAMs | Tumor-associated macrophages |
| TCGA | The Cancer Genome Atlas |
| TCF/LEF | T-cell factor/lymphoid enhancer factor |
| T-DXd | Trastuzumab deruxtecan |
| TGF-β | Transforming growth factor beta |
| TSC2 | Tuberous Sclerosis Complex 2 |
| UCEC | Uterine Corpus Endometrial Carcinoma |
| USC | Uterine Serous Carcinoma |
| VEGF | Vascular endothelial growth factor |
| VUS | Variants of uncertain significance |
| WEE1 | WEE1-like protein kinase |
| WHO | World Health Organization |
| WNT4 | Wnt Family Member 4 |